Use this button to switch between dark and light mode.

Experience a New Era in Legal Research with Free Access to Lexis+

Biogen Int'l GmbH v. Mylan Pharms. Inc.

Biogen Int'l GmbH v. Mylan Pharms. Inc.

Supreme Court of the United States

October 3, 2022, Decided

No. 21-1567.

Opinion

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.

Read The Full CaseNot a Lexis Advance subscriber? Try it out for free.

Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.

2022 U.S. LEXIS 3717 *; 143 S. Ct. 112; 214 L. Ed. 2d 28; 91 U.S.L.W. 3066; 2022 WL 4652058

Biogen International GmbH, et al., Petitioner v. Mylan Pharmaceuticals Inc.

Prior History: Biogen Int'l GmbH v. Mylan Pharms., Inc., 18 F.4th 1333, 2021 U.S. App. LEXIS 35254 (Fed. Cir., Nov. 30, 2021)

Judges:  [*1] Roberts, Thomas, Alito, Sotomayor, Kagan, Gorsuch, Kavanaugh, Barrett, Jackson.